CompanyDrug

Enhertu Wins China NMPA Approval for Second‑Line HER2‑Positive Gastric Cancer

CompanyDrug

AstraZeneca’s Imfinzi Wins China Approval for Endometrial Cancer, Securing Seventh Indication

CompanyMedical Device

HeartCare Medical’s Intracranial Drug‑Eluting Stent Gets NMPA Filing Nod

CompanyMedical Device

Abbott’s TactiFlex Duo Wins CE Mark for Atrial Fibrillation Treatment in Europe

CompanyDrug

Lilly’s Sofetabart Wins FDA Breakthrough Status for Platinum‑Resistant Ovarian Cancer

CompanyR&D

Ascletis Selects ASC37 as Clinical Candidate for Monthly Triple Agonist Therapy

CompanyDeals

Novavax Licenses Matrix-M Adjuvant to Pfizer in $530M Deal

CompanyDrug

Henlius’s HLX701 Gets NMPA Nod for Phase Ib/II Advanced CRC Combination Study

BioRay Pharmaceutical Files HKEX IPO, Backed by First‑in‑Class Autoimmune and Oncology Pipeline
CompanyDeals

BioRay Pharmaceutical Files HKEX IPO, Backed by First‑in‑Class Autoimmune and Oncology Pipeline

CompanyDeals

BMS Partners with Microsoft on AI‑Powered NSCLC Detection Platform

CompanyDeals

Bayer Partners with Vanderbilt in 5‑Year Deal to Accelerate Cardio‑Renal Drug Discovery

Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform
CompanyDeals

Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform